Market News

Syndax Pharmaceuticals, Inc. (SNDX) Reaches $9.48 After 9.00% Down Move; Plains All American Pipeline LP Has 0.63 Sentiment

Plains All American Pipeline, L.P., through its subsidiaries, engages in the transportation, storage, terminalling, and marketing of crude oil, natural gas liquids , natural gas, and refined products in the United States and Canada. The company has market cap of $16.23 billion. The Company’s Transportation segment transports crude oil and NGL through pipelines, gathering systems, trucks, and barges. It has a 23.56 P/E ratio. As of December 31, 2016, this segment owned and leased 19,200 miles of active crude oil and NGL pipelines and gathering systems; 31 million barrels of active and above-ground tank capacity; 810 trailers; 120 transport and storage barges; and 60 transport tugs.

The stock of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is a huge mover today! The stock decreased 4.44% or $0.44 during the last trading session, reaching $9.48. About 370,341 shares traded or 9.98% up from the average. Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) has risen 7.09% since February 18, 2017 and is uptrending. It has underperformed by 9.61% the S&P500.The move comes after 9 months negative chart setup for the $231.22 million company. It was reported on Feb, 18 by Barchart.com. We have $8.63 PT which if reached, will make NASDAQ:SNDX worth $20.81 million less.

Ratings analysis reveals 75% of Plains All American’s analysts are positive. Out of 8 Wall Street analysts rating Plains All American, 6 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $30.0 while the high is $37.0. The stock’s average target of $34.25 is 53.04% above today’s ($22.38) share price. PAA was included in 8 notes of analysts from September 9, 2016. On Monday, January 30 the stock rating was initiated by Mizuho with “Neutral”. The company was upgraded on Tuesday, January 31 by Robert W. Baird. The firm has “Overweight” rating given on Tuesday, October 4 by Morgan Stanley. The stock has “Outperform” rating by Wells Fargo on Wednesday, October 5. The company was upgraded on Thursday, October 13 by Piper Jaffray. The rating was upgraded by JP Morgan on Friday, December 9 to “Overweight”. The stock has “Sector Outperform” rating by Howard Weil on Monday, October 10. The firm earned “Mkt Perform” rating on Friday, September 9 by FBR Capital.

Rr Advisors Llc holds 7.92% of its portfolio in Plains All American Pipeline, L.P. for 2.76 million shares. C V Starr & Co Inc owns 70,000 shares or 6.9% of their US portfolio. Moreover, Alps Advisors Inc has 5.1% invested in the company for 33.96 million shares. The Texas-based Center Coast Capital Advisors Lp has invested 4.81% in the stock. Trust Asset Management Llc, a Texas-based fund reported 570,771 shares.

The stock decreased 0.71% or $0.16 during the last trading session, reaching $22.38. About 3.89 million shares traded or 0.25% up from the average. Plains All American Pipeline, L.P. (PAA) has risen 11.50% since February 18, 2017 and is uptrending. It has underperformed by 5.20% the S&P500.

Analysts await Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) to report earnings on March, 1. They expect $-0.93 EPS, down 57.63% or $0.34 from last year’s $-0.59 per share. After $-0.68 actual EPS reported by Syndax Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 36.76% negative EPS growth.

Leave a Reply

Your email address will not be published. Required fields are marked *